RIPK2 inhibitor 1 structure
|
Common Name | RIPK2 inhibitor 1 | ||
|---|---|---|---|---|
| CAS Number | 1290490-78-6 | Molecular Weight | 410.468 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C25H22N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RIPK2 inhibitor 1RIPK2 inhibitor 1 is a novel potent, selective RIPK2 inhibitor with IC50 of 5-10 nM; potently inhibits the proliferation of cancer cells by > 70% and also inhibits NF-κB activity. |
| Name | 3-(Benzoylamino)-4-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide |
|---|---|
| Synonym | More Synonyms |
| Description | RIPK2 inhibitor 1 is a novel potent, selective RIPK2 inhibitor with IC50 of 5-10 nM; potently inhibits the proliferation of cancer cells by > 70% and also inhibits NF-κB activity. |
|---|---|
| References | References 1. Salla M, et al. J Pharmacol Exp Ther. 2018 May;365(2):354-367. View Related Products by Target RIP kinase |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C25H22N4O2 |
| Molecular Weight | 410.468 |
| Exact Mass | 410.174286 |
| LogP | 3.46 |
| Index of Refraction | 1.641 |
| Benzamide, 3-(benzoylamino)-4-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)phenyl]- |
| 3-(Benzoylamino)-4-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide |
| MFCD31746634 |